Savara Inc. (Nasdaq: SVRA ) (the “Company”), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of the management team will participate in a ...

We need a system that treats the Bronx as a priority. If New York can build new subways for Manhattan, it can build a light ...

Key opportunities in the targeted drug delivery market include advances in precision medicine, next-gen carrier tech, strategic partnerships, resilient supply chains, and patient-centric design.

Then came notifications from the health department and Makayla's school that a measles exposure may have occurred at the ...

After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast ...

As many as half of all nursing home patients may benefit from respiratory therapy, given rising complexity and common conditions such as COPD, congestive heart failure and other chronic breathing and ...

Clarified return terms. When marketing language and Terms of Service provisions present different expectations, reconciling them proactively builds consumer trust. This applies to NebuEase's guarantee ...

LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) said the U.S. Food and Drug Administration does not plan to convene an advisory ...

I would have searched for care somewhere else.” The agent’s reply dumbfounded Wayman. “He said, ‘I’m sure you would have, ma‘am, but you owe it.’” “I was sick,” she said. “I could not sleep. I didn’t ...

These therapist-backed aids can help interrupt panic cycles and regulate your body in real time.

Aminoglycoside antibiotics (AGAs) were developed at the dawn of the antibiotics era and have significantly aided in the treatment of infectious diseases. Aminoglycosides have become one of the four ...

Savara Inc. (the "Company") , a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has received the Day 74 Letter from the FDA which indicated that ...